MiNK Therapeutics Inc. (INKT) is gearing up for a catalyst-packed 2026, with key milestones on the horizon - from the initiation of trials to new data readouts and multiple scientific presentations.
This clinical-stage biopharmaceutical company is developing innovative allogeneic invariant natural killer T (iNKT) cell therapies for cancer and immune-mediated diseases.
What Are iNKT Cells?
Before we dive into the details of the pipeline, here's what iNKT means in a nutshell.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.